A detailed history of Ransom Advisory, LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Ransom Advisory, LTD holds 11,540 shares of JNJ stock, worth $2.3 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
11,540
Previous 11,426 1.0%
Holding current value
$2.3 Million
Previous $2.12 Billion 99.89%
% of portfolio
0.94%
Previous 0.95%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 06, 2026

BUY
$185.98 - $199.58 $21,201 - $22,752
114 Added 1.0%
11,540 $2.3 Million
Q3 2025

Oct 07, 2025

BUY
$155.17 - $185.42 $1.77 Million - $2.12 Million
11,426 New
11,426 $2.12 Billion
Q3 2025

Oct 03, 2025

SELL
$155.17 - $185.42 $1.85 Million - $2.21 Million
-11,922 Closed
0 $2.12 Billion
Q2 2025

Jul 08, 2025

SELL
$146.36 - $159.82 $40,249 - $43,950
-275 Reduced 2.25%
11,922 $1.82 Billion
Q1 2025

May 20, 2025

BUY
$142.06 - $167.7 $1.73 Million - $2.05 Million
12,197 New
12,197 $2.02 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ransom Advisory, LTD Portfolio

Follow Ransom Advisory, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ransom Advisory, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ransom Advisory, LTD with notifications on news.